Assessment of end induction minimal residual disease (MRD) in childhood B precursor acute lymphoblastic leukemia (ALL) to eliminate the need for day 14 marrow examination: A Children's Oncology Group study

被引：0

作者：

Borowitz, Michael J.

Wood, Brent L.

Devidas, Meenakshi

Loh, Mignon L.

Raetz, Elizabeth A.

Larsen, Eric

Maloney, Kelly W.

Carroll, Andrew J.

Friedmann, Alison M.

Gastier-Foster, Julie M.

Heerema, Nyla A.

Mattano, Leonard A.

Nachman, James B.

Winick, Naomi Joan

Carroll, William L.

Hunger, Stephen

机构：

[1] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA

[2] Univ Washington, Seattle, WA 98195 USA

[3] Childrens Oncol Grp, Gainesville, FL USA

[4] Univ Calif San Francisco, San Francisco, CA 94143 USA

[5] NYU, Langone Med Ctr, New York, NY USA

[6] Maine Childrens Canc Program, Scarborough, ME USA

[7] Childrens Hosp Colorado, Aurora, CO USA

[8] Childrens Hosp Alabama, Birmingham, AL USA

[9] Massachusetts Gen Hosp, Boston, MA 02114 USA

[10] Nationwide Childrens Hosp, Columbus, OH USA

[11] Ohio State Univ, Ctr Comprehens Canc, Arthur G James Canc Hosp, Columbus, OH 43210 USA

[12] Richard J Solove Res Inst, Columbus, OH USA

[13] MSU KCMS, Kalamazoo, MI USA

[14] Univ Chicago, Chicago, IL 60637 USA

[15] Univ Texas SW Med Ctr Dallas, Ctr Canc & Blood Disorders, Childrens Med Ctr Dallas, Dallas, TX 75390 USA

[16] Univ Colorado Denver, Hlth Sci Ctr, Aurora, CO USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

10001

引用

页数：1